Tech Company Financing Transactions
Celtaxsys Funding Round
Celtaxsys closed a $17 million funding round on 3/31/2016. Backers included Domain Associates and private investors.
Transaction Overview
Company Name
Announced On
3/31/2016
Transaction Type
Venture Equity
Amount
$17,034,000
Round
Undisclosed
Investors
Domain Associates (Nicole Vitullo)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
311 Ferst Dr. Northwest 530
Atlanta, GA 30318
USA
Atlanta, GA 30318
USA
Phone
Website
Email Address
Not Recorded
Overview
Celtaxsys is a clinical-stage pharmaceutical development company focused on advancing novel foundational therapies to treat inflammation in rare, orphan designated diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Greg Duncan
Chief Scientific Officer
Eric Springman
VP - Finance
Angela Walsh
VP - Operations
Ralph Grosswald
Browse more venture capital transactions:
Prev: 3/31/2016: The Rogue Initiative venture capital transaction
Next: 3/31/2016: Cricket Health venture capital transaction
Share this article
About Database of VC Transactions
We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs